Skip to main content

Table 1 Shows sociodemographic characteristics of participants

From: Daily intake of 30 mg duloxetine is effective in decreasing premature ejaculation severity: a prospective randomized placebo-controlled cross over clinical trial

Participants (N = 68)

Median

IIEF-5a

24

baseline

 AIPEb

19

 IELT (Sec)c

60

 Male SQOLd

20

AIPE after duloxetineb

26

IELT after duloxetine (Sec)c

180

Male SQOL after duloxetined

43

AIPE after placebob

19

IELT after placebo (Sec)c

60

Male SQOL after placebod

21

  1. aIIEF-5  the international index of erectile function
  2. bAIPE  the Arabic index of premature ejaculation
  3. cIELT  Intravaginal ejaculatory latency time
  4. dMale SQOL (sexual quality of life questionnaire- male version) before and after treatment in both the placebo and the treatment groups. Chi2 test was used in this table